Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Acro Biomedical Co., Ltd.
  6. Summary
    ACBM   US0048921052

ACRO BIOMEDICAL CO., LTD.

(ACBM)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
09/09/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
4.85(c) 4.97(c) 4.99(c) 4.85(c) 4.98(c) Last
7 470 1 618 1 638 100 950 Volume
+21.55% +2.47% +0.40% -2.81% +2.68% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019 0,19 M - -
Net income 2019 -0,37 M - -
Net Debt 2019 0,07 M - -
P/E ratio 2019 -469x
Yield 2019 -
Sales 2020 0,69 M - -
Net income 2020 -0,12 M - -
Net Debt 2020 0,25 M - -
P/E ratio 2020 -1 179x
Yield 2020 -
Capitalization 272 M 272 M -
EV / Sales 2019 899x
EV / Sales 2020 202x
Nbr of Employees -
Free-Float 45,0%
More Financials
Company
Acro Biomedical Co., Ltd is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The Company intends to conduct research and development on its products based on cordyceps sinensis. Cordyceps is a fungus that is used in traditional Chinese medicine. Cordyceps sinensis is a medicine in old Chinese medical books and Tibetan medicine. It is a rare combination of a... 
Sector
Food Processing
Calendar
-
More about the company
All news about ACRO BIOMEDICAL CO., LTD.
08/23ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
08/23Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter End..
CI
05/24ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
05/24Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ende..
CI
04/02ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
04/02Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended De..
CI
2020Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ende..
CI
2020ACRO BIOMEDICAL : .Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CON..
AQ
2020ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
2020Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter End..
CI
2020ACRO BIOMEDICAL CO., LTD. : Submission of Matters to a Vote of Security Holders ..
AQ
2020ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
2020Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ende..
CI
2020ACRO BIOMEDICAL : 10-kt - management's discussion and analysis of financial cond..
AQ
2020Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ende..
CI
More news
News in other languages on ACRO BIOMEDICAL CO., LTD.

- No features available -

More news
Chart ACRO BIOMEDICAL CO., LTD.
Duration : Period :
Acro Biomedical Co., Ltd. Technical Analysis Chart | ACBM | US0048921052 | MarketScreener
Income Statement Evolution
Managers and Directors
Pao Chi Chu Chairman, President, CEO & Chief Financial Officer
Shi Tao Li Medical Director
Jer Li Lin Vice President-Technical
Shi Ming Li Medical Director
Cheng Hsiang Kao Managing Director
Sector and Competitors
1st jan.Capi. (M$)
ACRO BIOMEDICAL CO., LTD.0.00%272
BY-HEALTH CO., LTD.7.45%6 833
HERBALIFE NUTRITION LTD.-10.93%4 519
BALCHEM CORPORATION20.16%4 482
THE SIMPLY GOOD FOODS COMPANY11.54%3 350
MEDIFAST, INC.11.44%2 519